Opexa Therapeutics Inc. (OPXA) Rating Reiterated by Chardan Capital

Opexa Therapeutics Inc. (OPXA) Rating Reiterated by Chardan Capital


's stock had its "neutral" rating reiterated by equities research analysts at Chardan Capital in a research report issued to clients and investors on Friday. Several other brokerages have also recently issued reports on OPXA.



from Biotech News